Medication info
Aibastar Tablet 5/160 mg

Aibastar Tablet 5/160 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Huons Life Science Co., Ltd.
Appearance
Dark yellow, rectangular film-coated tablet
Packaging
28 tablets/box[(14 tablets/Alu-Alu X 2)], 30 tablets/bottle
Approval status
Active

MFDS item code 201705678 · Approved 2017.07.14 · Insurance code 052701170

Summary

Main use
Treatment of essential hypertension not adequately controlled with amlodipine or valsartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 80 mg. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 160 mg. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 10 mg or valsartan 160 mg, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80 mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.
Child dose
The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
Huons Life Science Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with amlodipine or valsartan monotherapy

  • Essential hypertension
View approved original text

This medication is indicated for patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with amlodipine or valsartan, allowing effective lowering and management of blood pressure. It combines the effects of both components to help dilate blood vessels and maintain stable blood pressure. Therefore, this medication can contribute to preventing complications and maintaining a healthy state in cases where blood pressure control is challenging.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 80 mg. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 160 mg. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 10 mg or valsartan 160 mg, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80 mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.

Child dose

The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication should not be taken during the second and third trimesters of pregnancy, as it can cause serious harm or death to the fetus; discontinue immediately upon confirmation of pregnancy. Those with allergies to this medication's active ingredients or to drugs in a similar category should not take it. Pregnant or nursing women, as well as those with severe kidney or liver dysfunction, should not take this medication. Patients with deficiencies in fluid or sodium should improve their condition before taking this medication; if symptoms of hypotension occur during treatment, lie down immediately and seek medical assistance if necessary. Patients with high potassium levels or those taking potassium supplements should monitor their potassium levels regularly. Patients with renal artery stenosis or those who have recently undergone kidney transplants should closely monitor kidney function when using this medication. If symptoms of angioedema occur, discontinue use immediately and do not re-administer. Patients with heart failure or post-myocardial infarction should periodically check kidney function and blood pressure while taking this medication, and consider the risk of pulmonary edema. Patients with acute myocardial infarction, aortic stenosis, or obstructive hypertrophic cardiomyopathy require special caution when using this medication. When combined with other antihypertensive medications, this medication may increase the risk of hypotension, hyperkalemia, and worsening kidney function; therefore, regular monitoring of blood pressure and blood tests is necessary as directed by a physician. Caution is needed when driving or operating machinery, as dizziness or fatigue may occur. In cases of overdose, severe hypotension or cardiac issues may result, so prescribed dosages must be adhered to, and you should seek immediate medical attention if any abnormal symptoms occur. This medication is not recommended for children under 18 years of age as safety and efficacy have not been established. The same dosage is recommended for the elderly as for adults, but caution may be warranted depending on the condition. Regular liver and kidney function tests are advisable during treatment, and consult a physician immediately if any abnormal symptoms arise.

Side effects

nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, itching, joint swelling, low back pain, arthritis, muscle cramps, lethargy, pollakiuria, polyuria, erectile dysfunction, edema, generalized edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, serum sickness including hypersensitivity, elevated serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste distortion, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, voiding dysfunction, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroexcitation, Stevens-Johnson syndrome, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Dark yellow, rectangular film-coated tablet

Package unit

28 tablets/box[(14 tablets/Alu-Alu X 2)], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.